OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1120$0.7956

Arts Optical International Holdings Ltd

Medical Equipment, Supplies & DistributionVerified

Arts Optical's capital structure shows a market cap of HKD 305.15 million and a price-to-book ratio of 0.54, indicating a discount to tangible book value. The company's liquidity position is moderate, with a current ratio of 1.19 and a debt-to-equity ratio of 0.63, suggesting manageable leverage but limited buffer against short-term obligations. Profitability metrics show a return on equity of 3.63% and a return on assets of 1.29%, both below the industry median for medical equipment and supplies. The gross margin of 31.4% (HKD 418.68 million gross profit on HKD 1.33 billion revenue) is in line with industry norms, but operating margin of 3.94% (HKD 52.56 million operating income) is weak, indicating pressure on cost control and pricing power. The company's revenue is split across three segments: Original Design and Manufacturing, Distribution, and Lens. No specific revenue concentration by geography is disclosed, but the company operates in both domestic and overseas markets. Property investments are mentioned but not quantified in the financial snapshot. Outlook data is not provided in the input, but based on historical revenue of HKD 1.33 billion and the company's exposure to the eyewear market, growth is likely to depend on global demand for eyewear and the company's ability to maintain or expand its market share. The company's property investments may also influence long-term growth. Risk factors include a negative net cash position after subtracting total debt, which raises liquidity concerns. The company's low dilution risk is supported by no difference between basic and diluted shares outstanding, but the debt-to-equity ratio of 0.63 suggests some leverage risk. No recent events or filings are provided in the input data to assess near-term risk. No recent events, filings, or transcripts are provided in the input data to assess recent developments or management commentary. The narrative is based solely on the financial snapshot and classification data.

30-day price · 1120-0.23 (-25.3%)
Low$0.67High$0.95Close$0.68As of22 May, 00:00 UTC
Profile
CompanyArts Optical International Holdings Ltd
Ticker1120.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Arts Optical International Holdings Ltd operates in the eyewear business through three segments: Original Design and Manufacturing, Distribution, and Lens, and also invests in properties.

Classification. Arts Optical is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Arts Optical's capital structure shows a market cap of HKD 305.15 million and a price-to-book ratio of 0.54, indicating a discount to tangible book value. The company's liquidity position is moderate, with a current ratio of 1.19 and a debt-to-equity ratio of 0.63, suggesting manageable leverage but limited buffer against short-term obligations. Profitability metrics show a return on equity of 3.63% and a return on assets of 1.29%, both below the industry median for medical equipment and supplies. The gross margin of 31.4% (HKD 418.68 million gross profit on HKD 1.33 billion revenue) is in line with industry norms, but operating margin of 3.94% (HKD 52.56 million operating income) is weak, indicating pressure on cost control and pricing power. The company's revenue is split across three segments: Original Design and Manufacturing, Distribution, and Lens. No specific revenue concentration by geography is disclosed, but the company operates in both domestic and overseas markets. Property investments are mentioned but not quantified in the financial snapshot. Outlook data is not provided in the input, but based on historical revenue of HKD 1.33 billion and the company's exposure to the eyewear market, growth is likely to depend on global demand for eyewear and the company's ability to maintain or expand its market share. The company's property investments may also influence long-term growth. Risk factors include a negative net cash position after subtracting total debt, which raises liquidity concerns. The company's low dilution risk is supported by no difference between basic and diluted shares outstanding, but the debt-to-equity ratio of 0.63 suggests some leverage risk. No recent events or filings are provided in the input data to assess near-term risk. No recent events, filings, or transcripts are provided in the input data to assess recent developments or management commentary. The narrative is based solely on the financial snapshot and classification data.
Key takeaways
  • Arts Optical trades at a discount to tangible book value (P/B of 0.54), suggesting potential undervaluation.
  • The company's return on equity (3.63%) and return on assets (1.29%) are below industry medians, indicating subpar profitability.
  • The debt-to-equity ratio of 0.63 and current ratio of 1.19 suggest moderate leverage and liquidity risk.
  • No specific revenue concentration by geography is disclosed, but the company operates in both domestic and overseas markets.
  • The company's property investments are mentioned but not quantified, leaving their impact on growth uncertain.
  • The company has low dilution risk, with no difference between basic and diluted shares outstanding.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$1.33B
Gross profit$418.7M
Operating income$52.6M
Net income$20.7M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$1.61B
Total liabilities$1.04B
Total equity$569.7M
Cash & equivalents
Long-term debt$361.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.33B$52.6M$20.7M-$45.6M
FY-1$1.28B$21.7M$11.4M-$147.2M
FY-2$1.20B$42.1M$51.3M-$26.6M
FY-3$1.14B$123.0M$114.8M$89.7M
FY-4$1.15B$28.4M$20.7M$3.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.61B$569.7M
FY-1$1.40B$520.0M
FY-2$1.28B$541.9M
FY-3$1.09B$519.2M
FY-4$1.12B$453.6M
PeriodOCFCapExFCFSBC
FY0-$39.6M-$133.3M-$45.6M
FY-1$54.7M-$184.0M-$147.2M
FY-2$68.1M-$79.6M-$26.6M
FY-3$99.8M-$63.6M$89.7M
FY-4-$44.8M-$42.6M$3.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.79
Market cap$305.1M
Enterprise value$666.6M
P/E14.7
Reported non-GAAP P/E
EV/Revenue0.5
EV/Op income12.7
EV/OCF
P/B0.5
P/Tangible book0.5
Tangible book$569.7M
Net cash-$361.4M
Current ratio1.2
Debt/Equity0.6
ROA1.3%
ROE3.6%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric1120Activity
Op margin3.9%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin1.6%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin31.4%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue3.0% medp25 2.7% · p75 4.5%
Debt / equity63.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:21 UTC#2814a6e9
Market quoteclose HKD 0.79 · shares 0.39B diluted
no public URL
2026-05-12 00:21 UTC#a36c1e55
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 00:24 UTCJob: aad588d1